Pubblicazioni

"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al

2022 - JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Serrao, Alessandra; Assanto, Giovanni Manfredi; Malfona, Francesco; Chavez Orellana, Gabriela; Chistolini, Antonio

Optimization by response surface methodology of a dispersive magnetic solid phase extraction exploiting magnetic graphene nanocomposite coupled with UHPLC-PDA for simultaneous determination of new oral anticoagulants (NAOs) in human plasma

2020 - JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Ferrone, V.; Todaro, S.; Carlucci, M.; Fontana, A.; Ventrella, A.; Carlucci, G.; Milanetti, E.

Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

2019 - INTERNAL AND EMERGENCY MEDICINE

Violi, F.; Pastori, D.

Apixaban interacts with haemoglobin: effects on its plasma levels

2018 - THROMBOSIS AND HAEMOSTASIS

Sacco, Monica; Lancellotti, Stefano; Berruti, Federico; Arcovito, Alessandro; Bellelli, Andrea; Ricciardelli, Tiziana; Autiero, Ida; Cavallo, Luigi; Oliva, Romina; De Cristofaro, Raimondo

Italian intersociety consensus on DOAC use in internal medicine

2017 - INTERNAL AND EMERGENCY MEDICINE

Prisco, D.; Ageno, W.; Becattini, C.; D'Angelo, A.; Davi, G.; De Cristofaro, R.; Dentali, F.; Di Minno, G.; Falanga, A.; Gussoni, G.; Masotti, L.; Palareti, G.; Pignatelli, P.; Santi, R. M.; Santilli, F.; Silingardi, M.; Tufano, A.; Violi, F.